0591-2367 : Raloxifene 60 mg Oral Tablet, Film Coated
NDC: | 0591-2367 |
Labeler: | Actavis Pharma, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Raloxifene |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | ANDA200825 |
Rev. Date: |
Appearance:
Markings: | WPI |
Shapes: |
Oval |
Colors: |
White |
Size (mm): | 12 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 0591-2367-01: 100 TABLET, FILM COATED IN 1 BOTTLE (0591‑2367‑01)
- 0591-2367-10: 1000 TABLET, FILM COATED IN 1 BOTTLE (0591‑2367‑10)
- 0591-2367-30: 30 TABLET, FILM COATED IN 1 BOTTLE (0591‑2367‑30)
Active Ingredients:
- Raloxifene Hydrochloride
Dosage Strength:
- 60 mg
Inactive Ingredients:
- Starch, Corn
- Lactose Monohydrate
- Citric Acid Monohydrate
- Silicon Dioxide
- Sodium Stearyl Fumarate
- Polysorbate 80
- Hypromelloses
- Titanium Dioxide
- Polyethylene Glycols
Pharmaceutical Classes:
- Estrogen Agonist/Antagonist [EPC]
- Selective Estrogen Receptor Modulators [MoA]
Related Products:
Based on records with the same trade name.- 69189-2367 Raloxifene 60 mg Oral Tablet, Film Coated by Avera Mckennan Hospital
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0591-2363Next: 0591-2368 >
Related Discussions:
raloxifene HCL evista lilly sa
prevention osteoporosis ## medical prescriptio for preventio of osteoporosis post menopausia... 1 reply
prevention osteoporosis ## medical prescriptio for preventio of osteoporosis post menopausia... 1 reply
raloxifene HCL
evista Lilly SA...
evista Lilly SA...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.